Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells

Hypertension

Volumn 60, Issue 2, 2012, Pages 396-403

  Gildea, John J ^a   Wang, Xiaoli ^b   Shah, Neema ^a   Tran, Hanh ^a   Spinosa, Michael ^c   Van Sciver, Robert ^a   Sasaki, Midori ^a   Yatabe, Junichi ^c   Carey, Robert M ^a   Jose, Pedro A ^d   Felder, Robin A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b SHENZHEN POLYTECHNIC   (China)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin type 2 receptor; cAMP; cGMP; dopamine receptors; NaKATPase; PP2A; renal proximal tubule cells; sodium transport

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN 2 RECEPTOR; CYCLIC AMP; CYCLIC GMP; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; FENOLDOPAM; PHOSPHOPROTEIN PHOSPHATASE 2A; SODIUM;

ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; NATRIURESIS; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; SODIUM ABSORPTION; SODIUM RETENTION; SODIUM TRANSPORT;

BIOLOGICAL TRANSPORT; CELL LINE; CELLS, CULTURED; CYCLIC AMP; CYCLIC GMP; HUMANS; KIDNEY TUBULES, PROXIMAL; PROTEIN PHOSPHATASE 2; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, DOPAMINE; SIGNAL TRANSDUCTION; SODIUM; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84864289587     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.194175     Document Type: Article

References (41)

1. Felder RA, Jose PA. Mechanisms of disease: The role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637-650. (Pubitemid 44655641)
2. Crowley SD, Coffman TM. In hypertension, the kidney rules. Curr Hypertens Rep. 2007;9:148-153. (Pubitemid 46779380)
3. Bertorello A, Hokfelt T, Goldstein M, Aperia A. Proximal tubule Na-K-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. Am J Physiol. 1988;254:F795-F801.
4. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol. 1989;257:F469-F477.
5. Pelayo JC, Fildes RD, Eisner GM, Jose PA. Effects of dopamine blockade on renal sodium excretion. Am J Physiol. 1983;245:F247-F253. (Pubitemid 13031342)
6. Olsen NV. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans. Dan Med Bull. 1998;45: 282-297. (Pubitemid 28313538)
7. Gildea JJ, Israel JA, Johnson AK, Zhang J, Jose PA, Felder RA. Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension. 2009;54:1070-1076.
8. Gildea JJ, Shah I, Weiss R, Casscells ND, McGrath HE, Zhang J, Jones JE, Felder RA. HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension. 2010;56:505-511.
9. Gildea JJ, Wang X, Jose PA, Felder RA. Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension. 2008;51:360-366. (Pubitemid 351159951)
10. Harris PJ. Regulation of proximal tubule function by angiotensin. Clin Exp Pharmacol Physiol. 1992;19:213-222.
11. Carey RM, Padia SH. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure. Trends Endocrinol Metab. 2008;19:84-87. (Pubitemid 351442917)
12. Chugh G, Lokhandwala MF, Asghar M. Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats. Am J Physiol Renal Physiol. 2011;300:F133-F138.
13. Hein L, Meinel L, Pratt RE, Dzau VJ, Kobilka BK. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol. 1997;11: 1266-1277. (Pubitemid 28041334)
14. Hunyady L, Bor M, Balla T, Catt KJ. Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem. 1994;269:31378-31382.
15. Brismar H, Asghar M, Carey RM, Greengard P, Aperia A. Dopamineinduced recruitment of dopamine D1 receptors to the plasma membrane. Proc Natl Acad Sci U S A. 1998;95:5573-5578. (Pubitemid 28224136)
16. Kruse MS, Adachi S, Scott L, Holtback U, Greengard P, Aperia A, Brismar H. Recruitment of renal dopamine 1 receptors requires an intact microtubulin network. Pflugers Arch. 2003;445:534-539. (Pubitemid 36286885)
17. Salomone LJ, Howell NL, McGrath HE, Kemp BA, Keller SR, Gildea JJ, Felder RA, Carey RM. Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension. 2007;49:155-161. (Pubitemid 46360355)
18. Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, Felder RA, Jose PA. Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension. 2005;45:804-810. (Pubitemid 40418385)
19. Cheng HF, Becker BN, Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest. 1996;97:2745-2752. (Pubitemid 26197089)
20. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soaresda-Silva P, Creswell K, Guillemette G, Sibley DR, Eisner G, Gildea JJ, Felder RA, Jose PA. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest. 2008;118:2180-2189. (Pubitemid 351872336)
21. Zeng C, Luo Y, Asico LD, Hopfer U, Eisner GM, Felder RA, Jose PA. Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension. 2003;42:787-792. (Pubitemid 37237326)
22. Zeng C, Asico LD, Wang X, Hopfer U, Eisner GM, Felder RA, Jose PA. Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension. 2003;42:724-729. (Pubitemid 36314582)
23. Csikos T, Balmforth AJ, Grojec M, Gohlke P, Culman J, Unger T. Angiotensin AT2 receptor degradation is prevented by ligand occupation. Biochem Biophys Res Commun. 1998;243:142-147. (Pubitemid 28414205)
24. Schulman IH, Raij L. The angiotensin II type 2 receptor: what is its clinical significance? Curr Hypertens Rep. 2008;10:188-193.
25. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension. 1999;33:1036-1042. (Pubitemid 29186405)
26. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A. 2002;99:3872-3877. (Pubitemid 34252198)
27. Hakam AC, Hussain T. Angiotensin II AT2 receptors inhibit proximal tubular Na-K-ATPase activity via a NO/cGMP-dependent pathway. Am J Physiol Renal Physiol. 2006;290:F1430-F1436. (Pubitemid 43830769)
28. Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int. 2002;62:790-798. (Pubitemid 35316708)
29. Siragy HM. The angiotensin II type 2 receptor and the kidney. J Renin Angiotensin Aldosterone Syst. 2010;11:33-36.
30. Gildea JJ. Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance. Curr Opin Nephrol Hypertens. 2009;18: 28-32.
31. Hanyaloglu AC, von Zastrow M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol. 2008;48:537-568. (Pubitemid 351738163)
32. Premont RT, Gainetdinov RR. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol. 2007;69:511-534. (Pubitemid 46457653)
33. Padia SH, Kemp BA, Howell NL, Keller SR, Gildea JJ, Carey RM. Mechanisms of dopamine d1 and Angiotensin type 2 receptor interaction in natriuresis. Hypertension. 2012;59:437-445.
34. de Gasparo M, Siragy HM. The AT2 receptor: fact, fancy and fantasy. Regul Pept. 1999;81:11-24. (Pubitemid 29248796)
35. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest. 1989;84:1849-1856. (Pubitemid 20016190)
36. Felder RA, Kinoshita S, Sidhu A, Ohbu K, Kaskel FJ. A renal dopamine-1 receptor defect in two genetic models of hypertension. Am J Hypertens. 1990;3:96S-99S. (Pubitemid 20380234)
37. Yang Z, Yu P, Asico LD, Felder RA, Jose PA. Protein phosphatase 2A B56- during development in the spontaneously hypertensive rat. Clin Exp Hypertens. 2004;26:243-254. (Pubitemid 38529796)
38. Villar VA, Jones JE, Armando I, Palmes-Saloma C, Yu P, Pascua AM, Keever L, Arnaldo FB, Wang Z, Luo Y, Felder RA, Jose PA. G proteincoupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem. 2009;284: 21425-21434.
39. Bosnyak S, Jones ES, Christopoulos A, Aguilar MI, Thomas WG, Widdop RE. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin Sci (Lond). 2011;121:297-303.
40. Nascimento NR, Kemp BA, Howell NL, Gildea JJ, Santos CF, Harris TE, Carey RM. Role of SRC family kinase in extracellular renal cyclic guanosine 3=,5=-monophosphate-And pressure-induced natriuresis. Hypertension. 2011;58:107-113.
41. Padia SH, Kemp BA, Howell NL, Gildea JJ, Keller SR, Carey RM. Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats. Hypertension. 2009;53:338-343.